期刊文献+

多模态分子影像对肝癌进展和血管生成的研究 被引量:2

Research on Liver Tumor Proliferation and Angiogenesis Based on Multi-Modality Molecular Imaging
原文传递
导出
摘要 通过对HCCLM3-fLuc-GFP肝癌的进展和血管生成的多模态成像分析,对肝癌细胞在体内生长的适应过程和级数生长特性,分别进行了生物自发荧光成像(bioluminescent imaging,BLI)研究、激发荧光成像(fluorescent imaging,FMI)研究和小动物计算机断层成像(micro-computed tomography,Micro-CT)研究,对采集的成像数据进行定性定量分析,并与肿瘤的体积测量数据进行了相关性分析。结果表明,肿瘤细胞在接种后第4天细胞数量基本为原接种数量的一半,第7天体内的细胞基本与接种数量相等,7天内细胞基本完成了体内的适应过程,之后肝癌细胞进入了快速增殖期。BLI成像、FMI成像均与肿瘤体积的测量结果高度相关(R2=0.9263,R2=0.9068)。通过计算机断层成像(Micro-CT),对肿瘤的新生血管进行分析,并用可视化的手段对肿瘤的血管新生特性进行三维显示,Micro-CT成像结果验证了BLI、FMI成像揭示的肿瘤生长后期的非指数生长特性。 To detect the HCC-LM3-fLuc-GFP tumor adaptive and exponential process of tumor progression,bioluminescent imaging(BLI) and fluorescent imaging(FMI) were used to calculate the bioluminescent intensity and fluorescent intensity.The results showed that in the first four days,tumor cells became fewer because of the phagocytosis and decomposition of the macrophage and the trypsins.At about the seventh day,the tumor cells were equal with the number of the cells on the first day.This adaptive process cost about one week.In the following days,the tumor began to mount up exponentially.A good linear correlation was found between the tumor sizes measured by caliper and the BLI signals(FMI signals) determined by the optical imaging(R2(tumor sizes and BLI signals)=0.9263;R2(tumor sizes and FMI signals)=0.9068;R2(BLI signals and FMI signals)=0.9961).In addition,to study the tumor angiogenesis,Micro-CT was used to visualize the tumor blood vessels.The figures clearly displayed the connection between the tumor blood vessel and heart,liver or lung blood vessels.
出处 《生物物理学报》 CAS CSCD 北大核心 2011年第4期355-364,共10页 Acta Biophysica Sinica
基金 "973"计划项目(2006CB705700 2011CB707700) 中国科学院知识创新工程重要方向项目(KGCX2-YW-907) 国家自然科学基金项目(81027002 81071205) 中国科学院百人计划 北京市教委科技重点项目(KZ200910005005)~~
关键词 生物自发荧光成像 激发荧光成像 计算机断层成像 肝癌进展 血管生成 Bioluminescent imaging Fluorescent imaging Micro-computed tomography Liver tumor proliferation Tumor angiogenesis
  • 相关文献

参考文献28

  • 1Vecchia CL, Lucchini F, Franceschi S, Negri E, Levi F. Trends in mortality from primary liver cancer in Europe. Eur J Cancer, 2000, 36: 909~915. 被引量:1
  • 2Jemal A, Tiwari RC, Thun MJ. Cancer statistics. Cancer J Clin, 2004, 54: 8~29. 被引量:1
  • 3Chen Z, Liu B, Chen J. Smoking and liver cancer in China: Case-control comparison of 36000 liver cancer deaths vs. 17000 cirrhosis deaths. Int J Cancer, 2003, 107(1): 106~112. 被引量:1
  • 4Zhao J, Dong L, Lu B, Wu G, Xu D, Chen J, Li K, Tong X, Dai J, Yao S, Wu M, Guo Y. Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis. Gastroenterology, 2008, 135: 956~968. 被引量:1
  • 5Zhao J, Lu B, Xu H, Tong X, Wu G, Zhang X, Liang A, Cong W, Dai J, Wang H, Wu M, Guo Y. Thirty-kilodalton tat-interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepato- cellular carcinoma. Hepatology, 2008, 48(1): 265~275. 被引量:1
  • 6Zhao J, Chen J, Lu B, Dong L, Wang H, Bi C, Wu G, Guo H, Wu M, Guo Y. TIP30 induces apoptosis under oxidative stress through stabilization of p53 messenger RNA in human hepatocellular carcinoma. Cancer Res, 2008, 68(11): 4133~4141. 被引量:1
  • 7Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ, Cerretti DP. A metalloproteinase disintegrin that releases tumor-necrosis factor-α from cells. Nature, 1997, 385(6618): 729~733. 被引量:1
  • 8Kindlmann GL, Weinstein DM, Jones GM, Johnson CR, Capecchi MR, Keller C. Practical vessel imaging by computed tomography in live transgenic mouse models for human tumors. Mol Imaging, 2005, 4: 417~424. 被引量:1
  • 9Laperle CM, Hamilton TJ, Philip W, Wakker EJ, Shi DX, Anastasio MA, Derdak Z, Wands JR, Diebold G, Petruck CR. Low density contrast agents for X-ray phase contrast imaging: The use of ambient air for X-ray angiography of excised murine liver tissue. Phys Med Biol, 2008, 53: 6911~6923. 被引量:1
  • 10Ntziachristos V, Ripoll J, Wang LV, Weissleder R. Looking and listening to light: The evolution of whole body photonic imaging. Nat Biotechnol, 2005, 23(3): 313~320. 被引量:1

同被引文献10

  • 1Willmann JK, Paulmurugan R, Chen K, et al. US imaging of tumor angiogenesis with mierobubbles targeted to vascular endothelial growth factor receptor type 2 in mice. Radiology, 2008,246 : 508-518. 被引量:1
  • 2Kassan DG, Lynch AM, Stiller MJ. Physical enhancement of dermatologic drug delivery: iontophoresis and phonophoresis. J Am Acad Dermatol, 1996,34:657-666. 被引量:1
  • 3Geis NA, Katus HA, Bekeredjian R, et al. Ultrasound targeted mierobubble destruction for drug and gene delivery. Expert Opin Drug Deliv, 2008,5 : 1121-1138. 被引量:1
  • 4Molina CA, Ribo M, Rubiera M, et al. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. Stroke, 2006,37 : 425-429. 被引量:1
  • 5Ryehak JJ, Graba J, Cheung AM, et al. Microultrasound molecular imaging of vascular endothelial grow factor receptor-2 in a mouse model of tumor angiogenesis. Mol Imaging, 2007,6: 289-296. 被引量:1
  • 6Zhang H,Li Y, Li H, et al. Inhibition of both the autocrine and the paraerine growth of human leukemia with a fully humaa antibody directed against vascular endothelial growth factor receptor 2. Leuk Lymphoma,2004,45 : 1887-1897. 被引量:1
  • 7刘忠华,刘贻尧,杨红.超声空化效应和超声微泡在生物医学中的应用[J].生物技术通讯,2008,19(3):475-478. 被引量:19
  • 8高顺记,李佩倞,赵洋,刘政,刘佳,张婵,谭开彬,高云华.微泡增强的超声空化阻断肿瘤微循环的初步研究[J].中国超声医学杂志,2010,26(2):110-112. 被引量:30
  • 9J.K.Willmann,A.M.Lutz,R.Paulmurugan,M.R.Patel,J.Rosen-berg,李芳.双定向超声对比剂在体评价肿瘤血管形成[J].国际医学放射学杂志,2008,31(A06):490-490. 被引量:49
  • 10冯若.超声空化与超声医学[J].中华超声影像学杂志,2004,13(1):63-65. 被引量:53

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部